Effects of 28 days of resistance exercise while consuming commercially available pre- and post-workout supplements, NO-Shotgun® and NO-Synthesize® on body composition, muscle strength and mass, markers of protein synthesis, and clinical safety markers in males by Spillane, Mike et al.
RESEARCH Open Access
Effects of 28 days of resistance exercise while
consuming commercially available pre- and post-
workout supplements, NO-Shotgun
® and NO-
Synthesize
® on body composition, muscle
strength and mass, markers of protein synthesis,
and clinical safety markers in males
Mike Spillane
1, Neil Schwarz
1, Sarah Leddy
1, Tracie Correa
1, Melodie Minter
1, Victoria Longoria
1 and
Darryn S Willoughby
1,2*
Abstract
Purpose: The effects of 28 days of heavy resistance training while ingesting the pre- and post-workout
supplements, NO-Shotgun
® and NO-Synthesize
® were determined on body composition, muscle strength and
mass, markers of protein synthesis, and clinical safety markers.
Methods: Nineteen non-resistance-trained males participated in a resistance training program 4 times/week for 28
days while either ingesting 27 g/day of carbohydrate (CARB) or NO-Shotgun
® 30 min pre-exercise and 27 g/day of
carbohydrate or NO- Synthesize
® 30 min post-exercise (NOSS). Data were analyzed with separate 2 × 2 ANOVA (p
< 0.05).
Results: Total body mass was increased in both groups (p = 0.001), but not different between groups. Fat
mass was unchanged with CARB, but NOSS decreased fat mass (p = 0.026). Both groups increased fat-free mass
(p = 0.001); however, the increases were greater with NOSS (p = 0.023). NOSS underwent greater increases in
upper-body (p = 0.023) and lower-body (p = 0.035) strength than CARB. Myofibrillar protein significantly increased
in both groups (p = 0.041), with NOSS being greater than CARB (p = 0.049). All of the MHC isoforms were
significantly increased in both groups; however, NOSS was greater than CARB for MHC 1 (p = 0.013) and MHC 2A
(p = 0.046). All of the myogenic regulatory factors were significantly increased in both groups; however, NOSS was
greater than CARB for Myo-D (p = 0.038) and MRF-4 (p = 0.001). For the whole blood and serum clinical chemistry
markers, all variables remained within normal clinical ranges.
Conclusions: Heavy resistance training for 28 days, with NO-Shotgun
® and NO-Synthesize
® ingested before and
after exercise, respectively, significantly improved body composition and increased muscle mass and performance
without abnormally impacting any of the clinical chemistry markers.
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Heavy resistance training augments muscle protein
synthesis [1-3], thereby resulting in increases in muscle
strength and hypertrophy [4-6]. It has been suggested
that the ingestion of specific nutrients (e.g., protein,
amino acids, carbohydrate, creatine, etc.) [7-10], or a
combination of nutrients (i.e., protein+carbohydrate,
protein+carbohydrate+creatine, protein+amino acids,
etc.) [11-13] within approximately one hour before and/
or after resistance exercise will augment substrate avail-
ability that is necessary during exercise and several
hours into the recovery period. The ingestion of either
protein or creatine before and after resistance exercise
for 16 weeks was shown to be more effective in increas-
ing muscle strength and satellite cell activation than
resistance training without nutrient provision [9]. We
have shown that ingesting protein (whey and casein)
and amino acids before and after resistance exercise for
10 weeks resulted in significantly greater increases in
muscle strength and mass compared to iso-caloric car-
bohydrate [13].
As a result, many recent studies have chosen to pro-
vide nutrients in close proximity (either before and/or
after) to resistance exercise [11-14]. This concept of
nutrient timing has been demonstrated in a 10 week-
study in which a supplement comprised of protein,
creatine, and glucose was given immediately before
and after each resistance exercise session or in the
morning and evening. Providing the supplement before
and after exercise resulted in a greater improvement in
muscle strength and mass, Type II muscle fiber cross-
sectional area, and contractile protein content [14].
However, more recently it was shown that a protein
supplement provided before and after resistance exer-
cise for 10 weeks was no more effective at increasing
muscle strength and mass compared to when the pro-
tein supplement was provided in the morning and eve-
ning [7]. As such, there appears to be disagreement in
the literature regarding this nutritional timing strategy
during resistance training, yet it continues to be con-
sidered to be a more effective method of bolstering
increases in muscle mass and strength compared to
resistance training without pre- and/or post-exercise
nutrient provision.
Recently we conducted a study to determine the
effects of an alleged pre-workout supplement and
demonstrated that four weeks of heavy resistance train-
ing in conjunction with the provision of the nutritional
supplement, NO-Shotgun
®, 30 min prior to each exer-
cise session was more effective at increasing muscle
strength and mass and markers indicative of muscle
protein synthesis and satellite cell activation when com-
pared to carbohydrate [15]. Based on our previous study
[15], and using the same experimental design in the pre-
sent study, we wanted to also provide a nutritional sup-
plement post-exercise to compare the effects compared
to carbohydrate.
Therefore, the purpose of this study was to compare
the effects of four weeks of heavy resistance training
performed in conjunction with either carbohydrate or
NO-Shotgun
® before and NO-Synthesize
® after each
exercise session on muscle strength, body composition,
markers of protein synthesis, and clinical safety markers
in men.
Methods
Participants
Nineteen apparently healthy, recreationally active, non-
resistance trained [no consistent (at least thrice weekly)
resistance training for one year prior to the study] males
with an average age of 22.8 ± 4.67 yr, height of 179.5 ±
6.38 cm, and total body mass of 79.1 ± 16.13 kg com-
pleted the study. Enrollment was open to men of all eth-
nicities. All participants passed a mandatory medical
screening. Participants with contraindications to exercise
as outlined by the American College of Sports Medicine
and/or who had consumed any nutritional supplements
(excluding multi-vitamins) such creatine monohydrate,
nitric oxide-stimulating, hydroxy-beta-methylbutyrate
(HMB), various androstenedione derivatives, or pharma-
cologic agents such as anabolic steroids three months
prior to the study were not allowed to participate. All
eligible participants signed a university-approved
informed consent document based on the guidelines set
forth by the Institutional Review Board for the Protec-
tion of Human Subjects of Baylor University. Addition-
ally, all experimental procedures involved in this study
conformed to the ethical considerations of the Helsinki
Code.
Testing sessions
The study included baseline testing at day 0 and a fol-
low-up testing session at day 29 in which blood and
muscle samples were obtained and where body compo-
sition and muscle performance tests were performed.
Strength assessment
Upper- and lower-body one repetition maximum (1-
RM) strength tests were performed using the free weight
bench press and angled leg press exercises (Nebula, Ver-
sailles, OH), respectively. Initially, an estimated 50% 1-
RM was utilized to complete 5 to 10 repetitions. After a
two min rest period, a load of 70% of estimated 1-RM
was utilized to perform 3 to 5 repetitions. Weight was
gradually increased until a 1-RM was reached with each
following lift, with a two min rest period in between
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these strength assessments on subjects within our
laboratory during the previous year has demonstrated
low mean coefficients of variation and high reliability
for the bench press (1.7%, intra-class r = 0.92) and leg
press (0.72%, intra-class r = 0.93), respectively.
Body composition assessment
Total body mass (kg) was determined on a standard
dual beam balance scale (Detecto Bridgeview, IL). Per-
cent body fat, fat mass, and fat-free mass were deter-
mined using DEXA (Hologic Discovery Series W,
Waltham, MA). Quality control calibration procedures
were performed on a spine phantom (Hologic X-CALI-
BER Model DPA/QDR-1 anthropometric spine phan-
tom) and a density step calibration phantom prior to
each testing session. The DEXA scans were segmented
into regions (right & left arm, right & left leg, and
trunk). Each of these segments was analyzed for fat
mass, lean mass, and bone mass. Based on previous
quality control testing in our laboratory from the pre-
vious year, the accuracy of the DEXA for body composi-
tion assessment is ± 2.3% as assessed by direct
comparison with hydrodensitometry and scale weight.
Total body water volume was determined by bioelectric
impedance analysis (Xitron Technologies Inc., San
Diego, CA) using a low energy, high frequency current
(500 micro-amps at a frequency of 50 kHz).
Venous blood sampling and percutaneous muscle
biopsies
Venous blood samples were obtained from the antecubi-
tal vein into a 10 ml collection tube using a standard
vacutainer apparatus. Blood samples were allowed to
s t a n da tr o o mt e m p e r a t u r ef o r1 0m i na n dt h e nc e n t r i -
fuged. The serum was removed and frozen at -80°C for
later analysis. Percutaneous muscle biopsies (50-70 mg)
were obtained from the middle portion of the vastus
lateralis muscle of the dominant leg at the midpoint
between the patella and the greater trochanter of the
femur at a depth between 1 and 2 cm. After sample
removal, adipose tissue was trimmed from the muscle
specimens, immediately frozen in liquid nitrogen, and
stored at -80°C for later analysis.
Supplementation protocol
Participants were assigned to a 28-day supplementation
protocol, in a double-blind, placebo-controlled manner.
Participants ingested either 54 g/day of maltodextrose
(CARB) or 27 g/day of NO-Shotgun
® and 27 g/day of
NO-Synthesize
® (NOSS). For CARB, 27 g were
ingested 30 min prior to exercise and 27 g within 30
min following exercise. NOSS ingested 27 g of NO-
Shotgun
® 30 min prior to exercise and 27 g/day NO-
Synthesize
® within 30 min following exercise. Immedi-
ately upon waking on non-training days, CARB
ingested 27 g of the supplement, whereas NOSS
ingested 27 g of NO-Synthesize
®. For supplementation
compliance, participants completed questionnaires and
returned empty containers dur i n gt h ep o s t - s t u d yt e s t -
ing session on day 29.
Dietary monitoring
In order to monitor dietary intake, participants were
required to record their food and drink intake for four
days prior to each of the two testing sessions at day 0
and day 29. For standardization purposes, participants’
diets were not standardized and subjects were asked not
to change their dietary habits during the course of the
study. The four-day dietary recalls were evaluated with
the Food Processor IV Nutrition Software (ESHA, Salem
OR) to determine the average daily macronutrient intake
of fat, carbohydrate, and protein for the duration of the
study.
Resistance-training protocol
Based on our previous study [15], participants com-
pleted a periodized 28-day resistance-training program
split into two upper-extremity and two lower-extremity
exercise sessions each week. This constituted a total of
16 exercise sessions, with eight upper-body and eight
lower-body exercise sessions. Prior to each exercise ses-
sion, participants performed a standardized series of
stretching exercises. The participants then performed an
upper-extremity resistance-training program consisting
of nine exercises (bench press, lat pull, shoulder press,
seated rows, shoulder shrugs, chest flies, biceps curl,
triceps press down, and abdominal curls) twice per week
and a program consisting of seven lower-extremity exer-
cises (leg press or squat, back extension, step ups, leg
curls, leg extension, heel raises, and abdominal
crunches). Participants performed three sets of 10 repe-
titions at 70 - 80% 1-RM. Rest periods were two min
between exercises and sets. The resistance exercise ses-
sions were not supervised; however, it was required that
each participant completed detailed daily resistance-
training logs.
Whole blood and serum clinical chemistry analyses
Whole blood was collected and immediately analyzed
for standard cell blood counts with percentage differen-
tials (hemoglobin, hemat o c r i t ,R B C ,M C V ,M C H ,
M C H C ,R D W ,W B Cc o u n t s ,n e u trophils, lymphocytes,
monocytes, eosinophils, basophils and leukocyte differ-
entials) using an automated hematology analyzer
(Sysmex XS-1000i, Mundelein, IL). The instrument’s
flow system was primed and the background counts
checked daily to ensure appropriate RBC and WBC
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the manufacturer, the coefficients of variation for the
Sysmex XS-1000i were 0.82%, 0.84%, 0.026%, 0.75%, and
0.82% for neutrophils, lymphocytes, monocytes, eosino-
phils, and basophils, respectively, and fell within the
recommended ranges.
Serum samples were out-sourced (Quest Diagnostics,
Dallas, TX) and assayed for general clinical chemistry
markers (total cholesterol, high-density lipoproteins,
low-density lipoproteins, triglycerides, albumin, glucose,
GGT, LDH, uric acid, BUN, creatinine, BUN/creatinine
ratio, calcium, creatine kinase, total protein, total biliru-
bin, ALP, ALT, and AST). Based on the methodology
employed for analysis, the coefficients of variation for all
analyses reported by Quest Diagnostics (Dallas, TX)
were no greater than 6%.
Serum IGF-1 analysis
Serum samples were analyzed in duplicate for IGF-1
(Enzo Life Sciences, Plymouth Meeting, PA) and HGF
(R&D Systems, Minneapolis, MN) using an ELISA. For
IGF-1, this assay has a sensitivity of 34.20 pg/ml and
does not cross-react with IGFBPs 2, 3, and 4, HGF, or
insulin. For IGF-1, the subsequent absorbances, which
were directly proportional to the concentration of ana-
lyte in the sample, were measured at a wavelength of
450 nm using a microplate reader (iMark, Bio-Rad, Her-
cules, CA). A set of standards of known concentrations
for IGF-1 was utilized to construct a standard curve by
plotting the net absorbance values of the standards
against the respective peptide concentrations. By apply-
ing a four-part parameter curve using data reduction
software (Microplate Manager, Bio-Rad, Hercules, CA),
the serum IGF-1 concentrations were calculated. The
overall intra-assay percent coefficient of variation was
5.3% for IGF-1.
Skeletal muscle cellular extraction
Each muscle sample was weighed and approximately 20
mg were homogenized using a commercial cell extrac-
tion buffer (Biosource, Camarillo, CA) and a tissue
homogenizer. The cell extraction buffer was supplemen-
ted with 1 mM phenylmethanesulphonylfluoride (PMSF)
and a protease inhibitor cocktail (Sigma Chemical Com-
pany, St. Louis, MO) with broad specificity for the inhi-
bition of serine, cysteine, and metallo-proteases.
Myogenic regulatory factor quantitation
The muscle protein expression of the MRFs was
assessed through the use of ELISA [15]. Polyclonal anti-
bodies specific for Myo-D, myogenin, and MRF-4 were
purchased from Santa Cruz Biotech (Santa Cruz, CA).
Initially, the antibodies were diluted to 1 μg/ml in coat-
ing buffer (Na2CO3, NaHCO3, and ddH2O, pH 9.6)
and allowed to incubate at room temperature overnight.
Following incubation, the plates were washed (1X phos-
phate buffered saline, Tween-20), blocked (10X phos-
phate buffered saline, bovine serum albumin, ddH2O),
washed, and then incubated with a secondary antibody
( I g Gc o n j u g a t e dt oH R P )d i l u t e dt o1μg/ml in dilution
buffer (10X phosphate buffered saline, Tween-20, bovine
serum albumin, ddH2O). After washing, a stabilized
TMB chromogen was added and the plates were covered
and placed in the dark for the last 30-min prior to being
stopped with 0.2 M sulphuric acid. The subsequent
absorbances, which were directly proportional to the
concentration of the MRFs in the samples, were mea-
sured at a wavelength of 450 nm. There were no stan-
dards used in these ELISAs, thus no standard curve was
created. Therefore, the absorbances relative to muscle
weight were assessed. The overall intra-assay percent
coefficients of variation were 7.12%, 6.47%, and 8.03%
for Myo-D, myogenin, and MRF-4, respectively.
Myofibrillar protein content
Myofibrillar protein was isolated from the skeletal mus-
cle cellular extracts with repeated incubations in 0.1%
SDS at 50°C and separated by centrifugation. Myofibril-
lar protein content was determined spectrophotometri-
cally based on the Bradford method at a wavelength of
595 nm [13,15]. A standard curve was generated (R =
0.99, p = 0.001) using bovine serum albumin (Bio-Rad,
Hercules, CA), and myofibrillar protein content was
expressed relative to muscle wet-weight.
Myosin heavy chain isoform protein quantitation
T h eM H Cp r o t e i ni s o f o r mc o m p o s i t i o nw i t h i n2 0μg
muscle homogenates was determined under denaturing
conditions using an Experion Pro260 automated electro-
phoresis system (Bio-Rad, Hercules, CA) using the prin-
ciples of SDS-PAGE and LabChip (Caliper Life Sciences,
Hopkinton, MA) technology [13]. The Experion Pro260
analysis kit has a resolution and quantitation of 10-260
kDa proteins while also separating and detecting 2.5-
2,000 ng/μl protein. The Experion Pro260 system com-
bines electrophoresis, staining, destaining, imaging, band
detection, and basic data analysis into a single, automated
step. Gel images were then processed and displayed on a
computer monitor and MHC bands identified by migra-
tion relative to the molecular weight marker (data not
shown). The density of the MHC bands was determined
using Experion Imaging software (Bio-Rad, Hercules,
CA), expressed in arbitrary density units.
Reported side effects from supplements
Participants reported by questionnaire at the testing ses-
sion on day 29 how well they tolerated the supplemen-
tation protocol, in addition to reporting any medical
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during the study.
Statistical analysis
Data were analyzed with separate 2 (group) × 2 (time)
ANOVA with repeated measures on the second factor
with SPSS 16.0 software (SPSS inc., Chicago, IL). Signifi-
cant differences among groups were identified by a
Tukey HSD post-hoc test. A probability level of < 0.05
was adopted throughout.
Results
Subject demographics
Twenty-two participants began the study; however, three
were withdrawn due to reasons unrelated to the study.
One participant contracted mononucleosis and another
injured his knee and neither were able to exercise for
several weeks. The third participant withdrew because
he did not have an adequate amount of time in his
schedule to remain compliant with the resistance train-
ing program. As a result, 19 participants completed the
study. The CARB group (n = 9) had an average (±SD)
age of 20.00 ± 1.41 yr, height of 179.75 ± 6.22 cm, and
total body mass of 81.43 ± 16.46 kg. The NOSS group
(n = 10) had an age of 21.20 ± 1.98 yr, height of 178.00
± 4.88 cm, and total body mass of 81.41 ± 29.39 kg.
Dietary analysis, supplement compliance, and reported
side effects
The diet logs were used to analyze the average daily
caloric and macronutrient consumption (Table 1).
Neither group significantly increased their caloric intake
during the course of the study. In addition, no signifi-
cant differences existed between groups for total caloric
(p = 0.129), protein (p = 0.216), carbohydrate (p =
0.106), and fat intake (p = 0.665).
All participants appeared to have exhibited 100% com-
pliance with the resistance training and supplementation
protocol, and were able to complete the required dosing
regimen and testing procedures. Over the course of the
28 days, two participants in CARB and three in NOSS
reported side effects. For CARB, both participants
reported feelings of nausea, one reported a rapid heart
rate, and one reported shortness of breath. For NOSS,
three participants reported dizziness, two reported feel-
ings of nausea, three reported headache, two reported a
rapid heart rate, one reported shortness of breath, and
one reported nervousness.
Body composition
Total body mass was significantly increased in both
groups with training (p = 0.001) with no significant
changes occurring in total body water (p = 0.345). Fat
mass was unchanged with CARB, but NOSS decreased
fat mass (p = 0.026). Both groups increased fat-free
mass with training (p = 0.001); however, the increases
were greater with NOSS (p = 0.023) (Table 2).
Muscle strength
For muscle strength, both groups underwent significant
increases with training; however, NOSS underwent
greater increases in upper-body (p = 0.023) and lower-
body (p = 0.035) strength compared to CARB (Table 2).
Serum IGF-1
Serum IGF-1 was significantly increased with training
(p = 0.038); however, NOSS and CARB did not differ
(p = 0.385) (Table 3).
Myogenic regulatory factors
All of the myogenic regulatory factors were significantly
increased in both groups; however, NOSS was greater
Table 1 Dietary caloric and macronutrient intake for the CARB and NOSS groups
Variable Group Day 0 Day 29 Test (p < .05) Group x Test (p < .05)
Total Calories (kcal/kg) .683 .129
NOSS 30.12 ± 9.94 31.61 ± 10.58
CARB 41.81 ± 18.98 35.41 ± 16.16
Protein (g/kg) .763 .216
NOSS 1.17 ± 0.33 1.25 ± 0.42
CARB 1.57 ± 0.77 1.31 ± 0.43
Carbohydrate (g/kg) .932 .106
NOSS 3.64 ± 1.39 4.01 ± 1.41
CARB 5.03 2.82 4.13 2.22
Fat (g/kg) .551 .665
NOSS 1.17 ± 0.41 1.15 ± 0.44
CARB 1.47 ± 0.64 1.27 ± 0.77
Data are presented as means and standard deviations.
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0.001) (Table 3).
Myofibrillar protein and MHC isoforms
Myofibrillar protein significantly increased in both
groups with training (p = 0.041), with NOSS being
greater than CARB (p = 0.049). All of the MHC iso-
forms were significantly increased in both groups with
training; however, NOSS was greater than CARB for
MHC 1 (p = 0.013) and MHC 2A (p = 0.046) (Table 3).
Serum and whole blood clinical chemistry markers
Serum creatinine was significantly increased with train-
ing (p = 0.016), but was not different between groups (p
= 0.413). In addition, basophils were significantly less at
Day 29 for NOSS (p = 0.05). Regarding all other serum
and whole blood clinical chemistry markers assessed,
there were no significant changes due to training or
between groups (p > 0.05), and all variables remained
within normal clinical ranges throughout the duration
of the study (Tables 4 and 5).
Discussion
The results of the present study indicate that NO-Shot-
gun
® and NO-Synthesize
® supplementation provided
before and after resistance exercise, respectively, and in
conjunction with heavy resistance training, is more
effective than carbohydrate at increasing fat-free mass,
muscle strength and mass, and markers of muscle pro-
tein synthesis in untrained males, while having no effect
on whole blood and serum clinical safety markers. In
regard to the various ingredients contained in both sup-
plements, based on previous research it is conceivable
that the primary active ingredients are whey protein,
creatine, leucine, beta-alanine, and KIC.
Our rationale to use carbohydrate as a comparator
was based on the premise that there is empirical evi-
dence to suggest that carbohydrate supplementation
prior to and after resistance exercise results in the
maintenance of muscle glycogen [16], in addition to the
fact that the insulin response associated with carbohy-
drate ingestion up-regulates signal transduction path-
ways in muscle which can activate muscle-specific gene
expression and protein synthesis [17]. Therefore, many
recent studies have provided nutrient provision in close
proximity (either before and/or after) to resistance exer-
cise and, in so doing, have used carbohydrate as a com-
parator based on the premise that carbohydrate
provided in conjunction with other nutrients such as
protein [17], amino acids [18], and creatine [11] has
Table 2 Body composition and muscle strength variables for the CARB and NOSS groups
Variable Group Day 0 Day 29 Test (p < .05) Group x Test (p < .05)
Body Mass (kg) .010* .793
NOSS 81.41 ± 16.46 82.64 ± 15.97
CARB 84.41 ± 29.39 85.44 ± 29.32
Body Water (kg) .345 .587
NOSS 43.07 ± 10.33 43.43 ± 9.68
CARB 43.18 ± 6.50 44.12 ± 7.13
Body Fat (%) .026* .014† NOSS < PLC
NOSS 17.88 ± 7.67 16.53 ± 7.35
CARB 21.18 ± 9.06 21.26 ± 9.55
Fat Mass (kg) .046* .026† NOSS < PLC
NOSS 14.21 ± 8.31 13.40 ± 8.10
CARB 18.64 ± 18.16 18.99 ± 18.64
Fat-Free Mass (kg) .001* .023† NOSS > PLC
NOSS 57.80 ± 8.01 59.92 ± 7.57
CARB 56.43 ± 10.33 57.02 ± 9.86
Upper-Body Strength (kg/kg) .016* .023† NOSS > PLAC
NOSS 1.03 ±0.15 1.16 ±0.21
CARB 1.07 ±0.25 1.08 ± 0.23
Lower-Body Strength (kg/kg) .001* .035† NOSS > PLAC
NOSS 4.04 ± 0.55 4.90 ± 0.64
CARB 4.19 ± 0.58 4.64 ± 0.84
Data are presented as means and standard deviations. * Denotes a significant increase at Day 29 compared to Day 0. † Denotes a significant difference between
CARB and NOSS.
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training.
Our results demonstrated that both NOSS and CARB
significantly increased total body mass (p = 0.001) with
no associated increases in total body water (p = 0.345).
Additionally, fat-free mass was increased in both groups
(p = 0.001) with NOSS demonstrating significantly
greater improvements than CARB (p = 0.023). These
findings for NOSS are similar to our previous study [15]
as well as a study that observed 12 weeks of heavy resis-
tance training and creatine supplementation to induce a
greater increase in fat-free mass compared to the carbo-
hydrate group [19]. In addition, 10 weeks of heavy resis-
tance training and whey protein and amino acid
supplementation resulted in greater increases in fat-free
mass compared to carbohydrate [13].
Increases in both upper- (p = 0.023) and lower-body (p =
0.035) muscle strength were significantly greater in NOSS
compared to CARB. The present data are corroborated by
our previous study [15], along with previous other studies
which have demonstrated heavy resistance training, when
combined with creatine [9,19] whey and casein protein
and amino acids [13], and whey protein and amino acids
[12] produces greater increases in muscle strength.
Our present results demonstrated that NOSS supple-
mentation results in preferential increases in myofibrillar
(p = 0.049) protein and Type I (p = 0.013) and IIa MHC
(p = 0.046) when compared to carbohydrate. Our results
are similar to a study in which creatine supplementation
in conjunction with 12 weeks of resistance training
resulted in an increase in myofibrillar protein and MHC
isoform content when compared to carbohydrate [19].
Additionally, a protein and amino acid supplement
ingested in concert with 10 weeks of heavy resistance
training induced a greater increase in myofibrillar pro-
tein compared to carbohydrate [13].
As with our previous study [15], we observed serum
IGF-1 to be increased with heavy resistance training
after four weeks; however, there was no difference
between groups (p = 0.385). Previous studies have
demonstrated heavy resistance training to either increase
[20] or have no effect [21] on serum IGF-1. We have
previously shown that 10 weeks of heavy resistance
training combined with a daily supplement containing
Table 3 Serum and muscle markers indicative of muscle protein synthesis for the CARB and NOSS groups
Variable Group Day 0 Day 29 Test (p < .05) Group x Test (p < .05)
IGF-1 (pg/ml) .038* .385
NOSS 3491.53 ± 597.34 3609.63 ± 497.11
CARB 3018.43 ± 690.91 3339.24 ± 70.94
Myofibrillar Protein (μg/mg) .041* .049† NOSS > PLC
NOSS 0.089 ± 0.019 0.115 ± 0.033
CARB 0.087 ± 0.128 0.092 ± 0.022
MHC 1 (arbitrary density units) .001* .013† NOSS > PLC
NOSS 1072.93 ± 206.16 1582.37 ± 247.55
CARB 1114.95 ± 448.29 1381.76 ± 423.04
MHC 2A (arbitrary density units) .001* .046† NOSS > PLC
NOSS 904.06 ± 500.22 1502.84 ± 412.07
CARB 944.11 ± 458.98 1385.97 ± 310.87
MHC 2X (arbitrary density units) .003* .244
NOSS 878.45 ± 328.28 731.70 ± 266.26
CARB 979.89 ± 226.74 676.78 ± 163.27
Myo-D (Abs/mg) .005* .038† NOSS > PLC
NOSS 1.72 ± 0.491 2.03 ± 0.399
CARB 1.65 ± 0.339 1.74 ± 0.462
Myogenin (Abs/mg) .017* .091
NOSS 1.63 ± 0.398 1.85 ± 0.422
CARB 1.57 ± 0.240 1.78 ± 0.405
MRF-4 (Abs/mg) .001* .001† NOSS > PLC
NOSS 1.87 ± 0.236 2.25 ± 0.247
CARB 1.83 ± 0.005 1.97 ± 0.003
Data are presented as means and standard deviations. * Denotes a significant increase at Day 29 compared to Day 0. † Denotes a significant difference between
CARB and NOSS.
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Page 7 of 11Table 4 Serum clinical chemistry markers for the CARB and NOSS groups
Variable Group Day 0 Day 29 Test (p < .05) Group x Test (p < .05)
Glucose (mg/dL) .142 .315
NOSS 82.00 ± 4.98 83.00 ± 11.45
CARB 81.80 ± 6.52 86.90 ± 5.56
BUN (mg/dL) .117 .117
NOSS 14.80 ± 3.42 14.80 ± 3.22
CARB 15.33 ± 2.82 12.88 ± 3.85
Creatinine (mg/dL) .016* .413
NOSS 0.896 ± 0.150 0.949 ± 0.145
CARB 0.916 ± 0.087 1.07 ± 0.201
Sodium (mmol/L) .304 .681
NOSS 137.40 ± 2.79 139.72 ± 2.26
CARB 136.67 ± 2.06 137.67 ± 9.08
Potassium (mmol/L) .107 .671
NOSS 4.06 ± 0.177 4.34 ± 0.568
CARB 3.95 ± 0.274 4.12 ± 0.446
Chloride (mmol/L) .665 .561
NOSS 101.70 ± 2.79 103.24 ± 2.85
CARB 101.33 ± 2.64 101.11 ± 8.47
CO2 (mmol/L) .787 .349
NOSS 21.40 ± 1.07 22.40 ± 1.07
CARB 20.11 ± 2.20 19.55 ± 4.90
Calcium (mg/dL) .799 .247
NOSS 9.27 ± 0.577 9.58 ± 0.322
CARB 9.28 ± 0.481 9.07 ± 1.24
Protein (mg/dL) .914 .336
NOSS 6.79 ± 0.645 6.95 ± 0.353
CARB 6.85 ± 0.657 6.65 ± 1.18
Albumin (mg/dL) .653 .244
NOSS 4.41 ± 0.338 4.50 ± 0.205
CARB 4.48 ± 0.341 4.28 ± 0.695
Globulin (mg/dL) .622 .622
NOSS 2.38 ± 0.410 2.45 ± 0.310
CARB 2.36 ± 0.393 2.36 ± 0.574
Albumin/Globulin .157 .436
NOSS 1.89 ± 0.237 1.87 ± 0.231
CARB 1.93 ± 0.300 1.86 ± 0.304
Bilirubin (mg/dL) .181 .465
NOSS 0.550 ± 0.295 0.440 ± 0.171
CARB 0.667 ± 0.282 0.633 ± 0.400
ALP (U/L) .066 .816
NOSS 52.30 ± 12.84 56.40 ± 18.36
CARB 58.55 ± 15.56 63.77 ± 21.77
AST (U/L) .982 .403
NOSS 17.80 ± 4.15 17.40 ± 4.67
CARB 17.55 ± 5.07 17.88 ± 4.59
ALT (U/L) .785 .785
NOSS 10.70 ± 4.16 10.70 ± 6.26
CARB 7.66 ± 1.93 8.33 ± 5.63
Data are presented as means and standard deviations. * Denotes a significant increase at Day 29 compared to Day 0.
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Page 8 of 11whey/casein protein and free amino acids increased cir-
culating IGF-1 levels [13]. Even though serum IGF-1
was increased in the present study, we can conceivably
conclude that none of the ingredients contained in the
supplements ingested by both groups served as IGF-1
secretagogues. Even so, this outcome may not be
germane to the results as hepatically-derived circulating
IGF-1 appears to have no direct effect on muscle hyper-
trophy [22] compared to skeletal-muscle derived IGF-I
which has been shown to increase in response to resis-
tance training [23] and induces muscular protein synth-
esis [24,25].
Table 5 Whole blood clinical chemistry markers for the CARB and NOSS groups
Variable Group Day 0 Day 29 Test (p < .05) Group x Test (p < .05)
WBC (10
6/L) .148 .300
NOSS 6.06 ± 1.32 5.91 ± 1.27
CARB 7.11 ± 1.74 6.28 ± 1.34
RBC (10
9/L) .243 .755
NOSS 4.99 ± 0.304 4.94 ± 0.257
CARB 4.94 ± 0.312 4.85 ± 0.302
HGB (g/dL) .100 .695
NOSS 15.24 ± 0.815 15.01 ± 0.750
CARB 14.96 ± 0.593 14.60 ± 0.563
HCT (%) .509 .997
NOSS 44.28 ± 2.12 43.92 ± 2.34
CARB 43.44 ± 1.81 43.08 ± 2.03
MCV (fL) .093 .226
NOSS 88.85 ± 3.90 88.90 ± 4.06
CARB 88.05 ± 4.00 88.86 ± 4.05
MCH (pg) .103 .886
NOSS 30.57 ± 1.31 30.42 ± 1.34
CARB 30.32 ± 1.85 30.14 ± 1.62
MCHC (g/dL) .015 .235
NOSS 34.42 ± 0.399 34.22 ± 0.482
CARB 34.45 ± 1.01 33.92 ± 1.03
Platelets (10
6/L) .243 .861
NOSS 211.24 ± 28.57 221.82 ± 38.27
CARB 228.89 ± 62.43 236.78 ± 77.51
Neutrophils (cells/μl) .178 .111
NOSS 2798.63 ± 1056.71 2868.65 ± 886.18
CARB 4038.93 ± 1448.59 3263.78 ± 767.91
Lymphocytes (cells/μl) .445 .566
NOSS 2512.93 ± 516.94 2344.63 ± 355.10
CARB 2164.57 ± 620.78 2139.84 ± 629.11
Monocytes (cells/μl) .613 .888
NOSS 536.70 ± 121.60 509.40 ± 124.70
CARB 599.11 ± 142.53 583.67 ± 263.01
Eosinophils (cells/μl) .602 .926
NOSS 186.40 ± 113.01 177.10 ± 143.54
CARB 287.33 ± 161.21 274.03 ± 183.27
Basophils (cells/μl) .293 .050† NOSS < PLC
NOSS 25.70 ± 10.34 17.40 ± 8.51
CARB 21.88 ± 11.43 24.55 ± 11.10
Data are presented as means and standard deviations. † Denotes a significant difference between CARB and NOSS.
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Page 9 of 11The MRFs (Myo-D, myogenin, MRF-4, myf5) are tran-
scription factors that play a role in muscle hypertrophy
by binding to E-boxes in the promoter region of various
sarcomeric genes [4], thereby up-regulating transcription
which can invariably lead to an increase in protein
synthesis. It appears that myogenin and MRF-4 specifi-
cally up-regulate the expression of genes specific to con-
tractile protein [26,27] and fast and slow muscle fiber
differentiation [28]. Type I and II muscle fibers have
been shown to preferentially accumulate myogenin and
Myo-D, respectively [26]. Creatine supplementation in
conjunction with resistance training has been shown to
increase MyoD, myogenin, and MRF-4 that were corre-
lated with increased MHC and myofibrillar protein [29]
and myofiber size [30]. In line with our previous studies,
the present results demonstrated that both groups
underwent significant increases in MRF content [15,29]
and all three MHCs [15,19]. However, NOSS underwent
even greater increases in Myo-D (p = 0.038) and MRF-4
(p = 0.001) and Type 1 and 2A MHC. It is difficult to
conclude which specific ingredient elicited these results;
however, based on previous research we can speculate a
role for creatine since 12 weeks of supplementation and
heavy resistance training resulted in muscle hypertrophy,
along with concomitant increases in MHC Type 1, 2A,
and 2X protein, and myofibrillar protein [19].
As with most nutritional supplements, NO-Shotgun
®
and NO-Synthesize
® are comprised of a number of differ-
ent compounds with most having no little, if any, clinical
safety data available. Durin gt h ec o u r s eo ft h es t u d y ,w e
observed no significant changes beyond the normal clini-
cal ranges in regard to clinical safety measures in either
group. These data indicate that the ingestion of carbohy-
drate, NO-Shotgun
®, and NO-Synthesize
® for a period of
28 days has no detrimental clinical effects with regard to
the whole blood and serum variables assessed.
A purpose of the present study was to compare the
effects of NO-Shotgun
® given pre-exercise and NO-
Synthesize
® given post-exercise to our previous study
(15) in which only NO-Shotgun
® was given pre-exercise
to determine if additional post-exercise nutrient provi-
s i o nw o u l dp r o v i d ea na u g m e n t e de f f e c t .O u rp r e s e n t
data showed that total body mass to increase by 1.51%
and fat-free mass to increase 3.66% in the NOSS group.
This mirrors the results observed in our previous study
in which the NO-Shotgun
® (NO) group increased 2.59%
and fat-free mass 4.75% (15). In our previous study,
upper- and lower-body strength increased 8.82% and
18.40%, respectively, with only lower-body being greater
than placebo (15). However, our present results show a
preferential increase of 12.62% and 21.28%, respectively,
for upper- and lower-body strength with both being
greater in NOSS. In our previous (15) and present
study, serum IGF-1 increased 9.34% and 3.38%,
respectively, with neither being different from placebo.
Myofibrillar protein was preferentially increased by
70.39% in the NO group in our previous study (15) and
29.21% in our present study. For the MRFs, in our pre-
vious study, they were preferentially increased in the
NO group by 70.91%, 56.24%, and 71.17% for Myo-D,
MRF-4, and myogenin, respectively. While still preferen-
tially increased in the NOSS group in our present study,
Myo-D, MRF-4, and myogenin increased 18.02%,
20.32%, and 13.49%.
NO-Shotgun
® and NO-Synthesize
® contain a proprie-
tary blend of a number of compounds assumed to be
effective at increasing muscle strength and mass such as
creatine, arginine, glutamine, beta-alanine, keto-iso-
caproate (KIC), and leucine, casein and whey protein,
branched-chain amino acids, lysine, phenylalanine,
threonine, histidine, and methionine. As a result,
attempting to isolate which specific ingredient has the
greatest impact on our outcome measures is not feasi-
ble. However, our present results indicate that supple-
mentation protocol of providing NO-Shotgun
® pre-
exercise, NO-Synthesize
® post-exercise, and NO-Synthe-
size
® on non-exercise days for 28 days is more effective
than carbohydrate at increasing muscle mass and
strength and markers indicative of muscle protein synth-
esis, while having no negative impact on the clinical
chemistry variables assessed. Furthermore, our present
results demonstrate preferential improvements in mus-
cle strength and mass and agree with our previous study
[15], and suggest that nutrient provision before and
after resistance exercise is effective in preferentially aug-
menting muscle strength and mass.
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